
MetLife (MET) Stock Forecast & Price Target
MetLife (MET) Analyst Ratings
Bulls say
MetLife is attractive because its diversified earnings base across Group Benefits, RIS, Asia, Latin America, EMEA, and MIM supports consistent profitability, with 3Q EPS of $2.78 modestly ahead of consensus and adjusted ROE near 20% helped by strong VII. Its U.S. franchises and international segments are all contributing, while capital-light businesses such as Group Benefits and Latin America should lift free cash flow, improve mix, and sustain earnings growth even as some mortality and disability trends normalize gradually. The firm also appears to be executing well on expenses and capital deployment, with a sub-12.1% direct expense ratio target, expected full-year 2026 VII above $1.6 billion, and management confidence that 2026 adjusted ROE will exceed the 15%–17% range.
Bears say
MetLife is viewed negatively because its earnings are highly exposed to lower interest rates, credit spread widening, and market volatility, which can pressure net investment income, reserve adequacy, and investment portfolio values. The company also faces downside from below-expected alternative asset returns, a possible slowdown in wage and employment growth, and mortality normalization, all of which could weaken profitability across its insurance and annuity businesses. Despite a diversified footprint with Group Benefits and RIS at around 52% of 2025 adjusted earnings, Asia at about 25%, and Latin America near 14% of 2024 earnings, global competition, FX risk, and regulatory uncertainty create material margin and growth pressure.
This aggregate rating is based on analysts' research of MetLife and is not a guaranteed prediction by Public.com or investment advice.
MetLife (MET) Analyst Forecast & Price Prediction
Start investing in MetLife (MET)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About MetLife (MET) Forecast
MetLife (MET) Analyst Forecast & Price Prediction
Start investing in MetLife (MET)
Order type
Buy in
Order amount
Est. shares
0 shares